WST
West Pharmaceutical Services Inc Earnings
$281.89
Earnings Summary
Revenue | $804.3Mn |
Net Profits | $140Mn |
Net Profit Margins | 17.41% |
West Pharmaceutical Services Inc’s revenue jumped 7.69% since last year same period to $804.3Mn in the Q3 2025. On a quarterly growth basis, West Pharmaceutical Services Inc has generated 4.97% jump in its revenue since last 3-months.
West Pharmaceutical Services Inc’s net profit jumped 2.94% since last year same period to $140Mn in the Q3 2025. On a quarterly growth basis, West Pharmaceutical Services Inc has generated 6.22% jump in its net profits since last 3-months.
West Pharmaceutical Services Inc’s net profit margin fell -4.41% since last year same period to 17.41% in the Q3 2025. On a quarterly growth basis, West Pharmaceutical Services Inc has generated 1.19% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | 1.68 |
EPS Estimate Current Year | 1.68 |
West Pharmaceutical Services Inc’s earning per share (EPS) estimates for the current quarter stand at 1.68 - a 11.26% jump from last quarter’s estimates.
West Pharmaceutical Services Inc’s earning per share (EPS) estimates for the current year stand at 1.68.
Key Ratios
Earning Per Share (EPS) | 0 |
Dividend Per Share (DPS) | 0.21 |
West Pharmaceutical Services Inc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the West Pharmaceutical Services Inc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
West Pharmaceutical Services Inc declared 0.21 dividend per share during the earnings announcement for Q3 2025.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-04-24 | 1.26 | 1.45 | 15.27% |
2025-07-24 | 1.51 | 1.84 | 21.85% |
2025-10-23 | 1.68 | 0 | -100% |
